Skip to main content
915 TLDR
Health
1 read

CDC Downplays Measles Outbreak Concerns Amid Rising Cases in Texas

KVIA••CNN Newsource
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

Recent outbreaks of measles across the United States, particularly a significant one in West Texas with 760 cases last year, have raised alarms about the country's elimination status for the virus. However, Dr. Ralph Abraham from the CDC stated that losing this status is not a major concern, emphasizing that vaccination remains the best preventive measure. The CDC reported that 93% of last year's cases were among unvaccinated individuals. The South Carolina outbreak is escalating, with over 500 individuals quarantined after exposure, primarily affecting children. Public health officials warn that the ongoing distrust in vaccinations is contributing to the rapid spread of measles, which is seen as preventable.

Key Details: • Last year's West Texas outbreak had approximately 760 cases. • In South Carolina, over 500 people are currently in quarantine due to exposure. • 93% of measles cases in the US last year were among unvaccinated individuals. • The CDC's next meeting regarding measles elimination status is in April. • Public health leaders are concerned about rising vaccination exemptions among kindergartners.

public-health cdc vaccination measles outbreak

People & Organizations

West TexasCDCSouth CarolinaHealth and Human ServicesDr. Demetre DaskalakisDr. Ralph AbrahamJosh GreenClemson UniversityAnderson University

Related Articles

KTSM•Feb 24

Novo Nordisk to Cut Prices of Popular Diabetes and Weight-Loss Medications

Novo Nordisk has announced a significant price reduction for its GLP-1 medications, including Ozempic, Wegovy, and Rybelsus, effective January 1, 2027. The list prices for these drugs will be reduced by up to 50%, bringing them down to $675 each. This move is expected to make these essential medications more accessible to patients managing diabetes and obesity, addressing the growing concerns over medication affordability. The change could impact many residents in El Paso who rely on these treatments for their health.

Health
1 min read
KTSM•Feb 24

El Paso Center for Diabetes to Host Overnight Camps for Teens in 2026

The El Paso Center for Diabetes is set to revive its youth overnight camps, with the first camp scheduled for April 10-12, 2026. This camp will cater to teenagers aged 12 to 17 and will take place in Angus, New Mexico, approximately 16 miles from El Paso. These camps aim to provide education and support for young individuals managing diabetes, fostering a sense of community and empowerment. Parents and guardians should mark their calendars for this opportunity to enhance their children's health and social skills.

Health
1 min read
KVIA•Feb 24

Novo Nordisk Cuts Prices of Ozempic and Wegovy by 50% Starting 2027

Novo Nordisk has announced a significant reduction in the list prices of its popular diabetes and weight loss medications, Ozempic, Wegovy, and Rybelsus, by up to 50% starting in 2027. The current list price for Wegovy is $1,349, while Ozempic and Rybelsus are priced at $1,028. This price cut aims to improve accessibility for patients, particularly those with high deductibles or co-insurance plans. The move comes as Novo Nordisk competes with Eli Lilly, which has gained market share in the obesity medication sector. Despite the list price reductions, self-pay prices will remain unaffected. The company recently reported disappointing trial results for its next-generation obesity drug, contributing to a decline in its stock price.

Health
1 min read
KVIA•Feb 24

Trump's Glyphosate Order Sparks Controversy Among Health Advocates in El Paso

An executive order by President Trump has declared glyphosate, a widely used herbicide, essential for national security and economic stability, which has drawn ire from health advocates, particularly those associated with the 'Make America Healthy Again' (MAHA) movement. The order emphasizes the need for a domestic supply of glyphosate, despite ongoing health concerns about its potential carcinogenic effects. Critics, including Zen Honeycutt of Moms Across America, argue that this move may protect Monsanto from lawsuits related to glyphosate's health risks. The order coincides with Bayer's proposed $7.25 billion settlement over cancer claims linked to Roundup, the product containing glyphosate. Health experts warn of the herbicide's risks, especially to children, as studies indicate increased cancer risks associated with exposure.

Health
1 min read